Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study.
暂无分享,去创建一个
D. Planchard | T. Yap | T. Guren | S. Kao | H. Kindler | I. Matos | K. Nakagawa | R. Shapira-Frommer | L. Calabrò | F. Jin | N. Fujimoto | K. Kuribayashi | B. Gao | A. Chatterjee | K. Norwood